Efbemalenograstim alfa for primary prophylaxis of chemotherapy-induced neutropenia in patients with ovarian and cervical cancer: A single-arm, multicenter clinical trial.

Authors: Limei Wang, Beihua Kong, Jie Jiang, Yang Shen, Jingyun Xu, Lixin Sun, Hongwei Zhao, Tao Zhu, Zhuyan Shao, Li Sun, Lei Sui

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17566

Source: Full article


Abstract

e17566